Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
This study has been completed.
Sponsor:
BioCryst Pharmaceuticals
Information provided by:
BioCryst Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00035022
First received: May 2, 2002
Last updated: January 12, 2006
Last verified: February 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | March 2004 |
| Estimated Primary Completion Date: | No date given |